Remove tag highlight-therapeutics
article thumbnail

PharmaShots Weekly Snapshots (April 10 - 14, 2023)

PharmaShots

Ocugen Reports Preliminary Results from the P-I/II Trial of OCU400 for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis Date: Apr 14, 2023 | Tags: Ocugen, OCU400, Retinitis Pigmentosa, Leber Congenital Amaurosis, Clinical Trial, P-I/II Trial Candesant Biomedical Receives the US FDA Clearance of Brella SweatControl Patch for Primary (..)

FDA 40
article thumbnail

PharmaShots Weekly Snapshots (June 19 – 23, 2023)

PharmaShots

Gilead Receives EMA’s CHMP Positive Opinion of Trodelvy (sacituzumab govitecan) for Pre-Treated HR+/HER2- Metastatic Breast Cancer Date: June 23, 2023 | Tags: Gilead, Trodelvy, sacituzumab govitecan, HR+/HER2- Metastatic Breast Cancer, Regulatory, EMA, CHMP, Positive Opinion Sarepta Therapeutics’ Elevidys Receives the US FDA’s Accelerated (..)

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

bluebird bio wins back-to-back landmark FDA approvals for first-in-class gene therapies

Pharmaceutical Technology

Spark Therapeutics’ Luxturna, indicated for inherited retinal disease (IRD), was the first gene therapy to be approved, in 2017, with a price tag of $850,000 for each eye. Gene therapies for rare inherited diseases are very expensive, as they tend to be the only therapeutic option available to patients and are often curative.

FDA 115
article thumbnail

PharmaShots Weekly Snapshots (April 17 - 21, 2023)

PharmaShots

Oblato Reports the First Patient Enrolment of OKN-007 in the P-I Clinical Trial for Recurrent High-Grade Glioma Date: Apr 21, 2023 | Tags: Oblato, OKN-007, Recurrent High-Grade Glioma, Regulatory, Henry Ford Health System CARsgen's CT041 Receives the US FDA’s IND Clearance for the Postoperative Adjuvant Therapy of Pancreatic Cancer Date: (..)

FDA 40
article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

The review stated that therapeutic innovation has resulted in the production of expensive drugs to treat rare diseases, which need to be available on time. Smart contracts, which are essential for easing international trade and logistics operations, can enable the user to track fake returns to the producer and supplier using RFID tags.

90
article thumbnail

Patent wars: what’s behind Amgen’s possible win over Sanofi at the US Supreme Court

Pharmaceutical Technology

However, Sanofi’s side also has significant support, highlighting the dispute’s contentious nature. Both drugs come with a high price tag. On the other side, Sanofi argues that Amgen’s patent claim is not enabled because it covers thousands of possible antibodies, but the patent application only highlights a few examples, he adds.

FDA 104
article thumbnail

The “Graziella Molinari Women in Pharma Award” Announced for 2022 Edition at the ISPE Italy Affiliate

ISPE

Winner of the ISPE Italy Affiliate’s Women in Pharma® Graziella Molinari Award in 2021, thanks to her project for the inclusion of #smart tags in a site production in order to improve not only efficiency, but also quality and compliance in a 4.0 trillion dollars in global turnover. Micaela Prati. perspective. .

98